Picture of Ocugen logo

OCGN Ocugen Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Annual cashflow statement for Ocugen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-58.4-81.4-63.1-54.1-67.8
Depreciation
Non-Cash Items7.7611.613.56.289.02
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital2.449.2-13.23.67-0.523
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-47.9-60.1-62.1-42.1-57
Capital Expenditures-1.07-4.46-10.5-3.38-0.185
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-0.75-12.513.60-0.126
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1.82-173.08-3.38-0.311
Financing Cash Flow Items-8.53-0.592-0.423-3.7-1.53
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities12159.520.964.917.3
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash70.9-17.5-38.119.4-39.9